Yihuan Xu

Yihuan Xu has extensive work experience in the field of biostatistics. They started their career as a Biostatistician at Thomas Jefferson University in 2004 and worked there until 2008. After that, they joined Eli Lilly and Company - NY/NJ as an Associate Director of Biostatistics and held that position for a decade, from 2008 to 2018. In 2018, Yihuan Xu moved to BeiGene as an Associate Director of Biostatistics and worked there until 2020. Currently, they are employed at TG Therapeutics, Inc. as a Senior Director of Biostatistics, starting from March 2020.

Yihuan Xu holds a Doctor of Philosophy (Ph.D.) degree in Statistics from Temple University. Prior to that, they earned a Master of Science (M.S.) degree in Statistics from the University of Delaware. They also have a second M.S. degree from the University of Delaware, this time in Molecular Biology. Additionally, Yihuan Xu obtained a Doctor of Medicine (M.D.) degree in Medicine from Peking University Health Science Center.